Entries of Holler, E on the publication server

Ahmed, S S, Wang, X N, Norden, J, Pearce, K, El-Gezawy, E, Atarod, S , Hromadnikova, I , Collin, M, Holler, E and Dickinson, A M (2015) Identification and validation of biomarkers associated with acute and chronic graft versus host disease. Bone Marrow Transplantation 50 (12), pp. 1563-1571. Fulltext not available.

Balavarca, Y, Pearce, K, Norden, J, Collin, M, Jackson, G, Holler, E, Dressel, R , Kolb, H-J, Greinix, H, Socie, G, Toubert, A , Rocha, V, Gluckman, E, Hromadnikova, I , Sedlacek, P, Wolff, D, Holtick, U, Dickinson, A and Bickeböller, H (2015) Predicting survival using clinical risk scores and non-HLA immunogenetics. Bone Marrow Transplantation 50 (11), pp. 1445-1452. Fulltext not available.

Blecha, C, Wolff, D, Kölbl, O, Huber, E, Helbig, H, Holler, B, Holler, E and Dietrich-Ntoukas, T (2014) Isolated orbital relapse of multiple myeloma in a patient with severe chronic GVHD after allogeneic hematopoietic SCT. Bone Marrow Transplantation 49 (7), pp. 988-989. Fulltext not available.

Ruutu, T, Gratwohl, A, de Witte, T, Afanasyev, B , Apperley, J, Bacigalupo, A, Dazzi, F , Dreger, P, Duarte, R, Finke, J, Garderet, L, Greinix, H, Holler, E, Kröger, N, Lawitschka, A, Mohty, M, Nagler, A, Passweg, J, Ringdén, O, Socié, G, Sierra, J, Sureda, A, Wiktor-Jedrzejczak, W, Madrigal, A and Niederwieser, D (2014) Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice. Bone Marrow Transplantation 49 (2), pp. 168-173. Fulltext not available.

Weissinger, E M, Metzger, J , Dobbelstein, C, Wolff, D, Schleuning, M, Kuzmina, Z, Greinix, H, Dickinson, A M, Mullen, W, Kreipe, H, Hamwi, I, Morgan, M, Krons, A, Tchebotarenko, I, Ihlenburg-Schwarz, D, Dammann, E, Collin, M, Ehrlich, S, Diedrich, H, Stadler, M, Eder, M, Holler, E, Mischak, H , Krauter, J and Ganser, A (2014) Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation. Leukemia 28 (4), pp. 842-852. Fulltext not available.

Mielke, S , Lutz, M , Schmidhuber, J, Kapp, M, Ditz, D, Ammer, J, Einsele, H, Grigoleit, G U, Holler, E and Wolff, D (2014) Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis. Bone Marrow Transplantation 49 (11), pp. 1412-1418. Fulltext not available.

Herzberg, P Y, Lee, S J, Heussner, P, Mumm, F H A, Hilgendorf, I, von Harsdorf, S, Hemmati, P, Rieger, K, Greinix, H T, Freund, M, Holler, E and Wolff, D (2013) Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center. Bone Marrow Transplantation 48 (1), pp. 129-134. Fulltext not available.

Ammer, J, Prantl, L, Holler, B, Landfried, K, Wolff, D, Karrer, S, Andreesen, R and Holler, E (2012) Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor. Bone Marrow Transplantation 47 (10), pp. 1368-1369. Fulltext not available.

Schreyer, A G , Landfried, K, Zorger, N, Hoffstetter, P, Ammer, J, Fellner, C, Friedrich, C, Andreesen, R, Holler, E and Jung, E M (2011) Transmural penetration of intravenously applied microbubbles during contrast-enhanced ultrasound as a new diagnostic feature in patients with GVHD of the bowel. Bone Marrow Transplantation 46 (7), pp. 1006-1011. Fulltext not available.

Holler, E, Kolb, H J, Greinix, H, Perrotin, D, Campilho, F, Aversa, F , Gil, L, Cornelissen, J, Varanese, L, Schacht, A, Friese, A and Rustige, J (2009) Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD. Bone Marrow Transplantation 43 (6), pp. 491-497. Fulltext not available.

Bouazzaoui, A , Spacenko, E, Mueller, G, Miklos, S, Huber, E, Holler, E, Andreesen, R and Hildebrandt, G C (2009) Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease. Genes & Immunity 10 (8), pp. 687-701. Fulltext not available.

Knop, S, Hebart, H, Gratwohl, A, Kliem, C, Faul, C, Holler, E, Apperley, J, Kolb, H J, Schaefer, A, Niederwieser, D and Einsele, H (2007) Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party. Leukemia 21 (8), pp. 1830-1833. Fulltext not available.

Knop, S, Hebart, H, Gscheidle, H, Holler, E, Kolb, H-J, Niederwieser, D and Einsele, H (2005) OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease. Bone Marrow Transplantation 36 (9), pp. 831-837. Fulltext not available.

Wolff, D, Roessler, V, Steiner, B, Wilhelm, S, Weirich, V, Brenmoehl, J, Leithaeuser, M, Hofmeister, N, Junghanss, C, Casper, J, Hartung, G, Holler, E and Freund, M (2005) Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplantation 35 (10), pp. 1003-1010. Fulltext not available.

Ruutu, T, Corradini, P , Gratwohl, A, Holler, E, Apperley, J, Dini, G, Rocha, V, Schmitz, N, Socié, G and Niederwieser, D (2005) Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation 35 (2), pp. 121-124. Fulltext not available.

Hegenbart, U, Niederwieser, D, Forman, S, Holler, E, Leiblein, S, Johnston, L, Pönisch, W, Epner, E, Witherspoon, R, Blume, K and Storb, R (2003) Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biology of Blood and Marrow Transplantation 9 (11), pp. 689-697. Fulltext not available.

Pihusch, R, Wegner, H, Salat, C, Pihusch, M, Holler, E, Kolb, HJ and Hiller, E (2002) Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 30 (6), pp. 381-387. Fulltext not available.

Jarvis, M, Schulz, U, Dickinson, A M, Sviland, L, Jackson, G, Konur, A, Wang, X N, Hromadnikova, I , Kolb, H J, Eissner, G and Holler, E (2002) The detection of apoptosis in a human in vitro skin explant assay for graft versus host reactions. Journal of Clinical Pathology 55 (2), pp. 127-132. Fulltext not available.

Pihusch, R, Holler, E, Mühlbayer, D, Göhring, P, Stötzer, O, Pihusch, M, Hiller, E and Kolb, H-J (2002) The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation. Bone Marrow Transplantation 30 (6), pp. 347-354. Fulltext not available.

Runde, V, Ross, S, Trenschel, R, Lagemann, E, Basu, O, Renzing-Köhler, K, Schaefer, UW, Roggendorf, M and Holler, E (2001) Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplantation 28 (1), pp. 51-57. Fulltext not available.

Einsele, H, Bertz, H, Beyer, J , Kiehl, M, Runde, V, Kolb, H.-J, Holler, E, Beck, R, Schwerdfeger, R, Schumacher, U, Hebart, H, Martin, H, Kienast, J, Ullmann, A, Maschmeyer, G, Krüger, W, Link, H, Schmidt, C, Oettle, H and Klingebiel, T (2001) Epidemiologie und interventionelle Therapiestrategien infektiöser Komplikationen nach allogener Stammzelltransplantation. DMW - Deutsche Medizinische Wochenschrift 126 (45), pp. 1278-1284. Fulltext not available.

Sviland, L, Hromadnikova, I , Sedlacek, P, Cermakova, M, Stechova, K, Holler, E, Eissner, G, Schulz, U, Kolb, H.J, Jackson, G, Wang, X.N and Dickinson, A.M (2001) Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation. Human Immunology 62 (11), pp. 1277-1281. Fulltext not available.